SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Citibank, N.A./ADR – ‘F-6 POS’ on 8/10/20 re: Xiaobai Maimai Inc.

On:  Monday, 8/10/20, at 4:42pm ET   ·   Effective:  8/10/20   ·   Accession #:  1193805-20-990   ·   File #:  333-220966

Previous ‘F-6 POS’:  ‘F-6 POS’ on 7/31/20   ·   Next:  ‘F-6 POS’ on 8/26/20   ·   Latest:  ‘F-6 POS’ on 4/26/24   ·   7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/10/20  Citibank, N.A./ADR                F-6 POS     8/10/20    3:680K Hexindai Inc.                     E-Data Systems, Inc./FA

Post-Effective Amendment of an ‘F-6EF’ Registration   —   Form F-6
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: F-6 POS     Post-Effective Amendment of an 'F-6EF'              HTML     33K 
                Registration                                                     
 2: EX-99.(A)(I)  Miscellaneous Exhibit                             HTML    143K 
 3: EX-99.(A)(II)  Miscellaneous Exhibit                            HTML    324K 


‘F-6 POS’   —   Post-Effective Amendment of an ‘F-6EF’ Registration


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

As filed with the Securities and Exchange Commission on August 10, 2020 Registration No. 333 - 220966

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-6 

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933 FOR DEPOSITARY SHARES EVIDENCED BY

AMERICAN DEPOSITARY RECEIPTS

 

 

 

hexindai inc. 

(Exact name of issuer of deposited securities as specified in its charter)

 

 

 

N/A 

(Translation of issuer’s name into English)

 

 

 

The Cayman Islands

(Jurisdiction of incorporation or organization of issuer)

 

 

 

CITIBANK, N.A.

(Exact name of depositary as specified in its charter)

 

 

 

388 Greenwich Street 

New York, New York 10013

(877) 248 - 4237

(Address, including zip code, and telephone number, including area code, of depositary’s principal executive offices)

 

 

 

Cogency Global Inc.

122 East 42nd Street, 18th Floor

New York, NY 10168

(800) 221-0102

(Address, including zip code, and telephone number, including area code, of agent for service)

 

 

 

Copies to:

Stephanie Tang, Esq.

Hogan Lovells

11th Floor, One Pacific Place

88 Queensway

Hong Kong

 

Herman H. Raspé, Esq.

Patterson Belknap Webb & Tyler LLP

1133 Avenue of the Americas

New York, New York 10036

(212) 336-2301

 

 

 

It is proposed that this filing become effective under Rule 466: immediately upon filing.
     
 

on (Date) at (Time).

 

If a separate registration statement has been filed to register the deposited shares, check the following box: o

 

The Registrant hereby amends this Post-Effective Amendment No. 1 to Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Post-Effective Amendment No. 1 to Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, or until this Post-Effective Amendment No. 1 to Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

 

 C: 

  

This Post-Effective Amendment No. 1 to Registration Statement on Form F-6 may be executed in any number of counterparts, each of which shall be deemed an original, and all of such counterparts together shall constitute one and the same instrument.

 

 C: 

 C: ii

 

PART I

 

INFORMATION REQUIRED IN PROSPECTUS

 

Cross Reference Sheet

 

Item 1.DESCRIPTION OF SECURITIES TO BE REGISTERED

 

Item Number and Caption

 

Location in Form of American

Depositary Receipt (“Receipt”)
Filed Herewith as Prospectus

         
1. Name of Depositary and address of its principal executive office   Face of Receipt -  Introductory Article.
       
2. Title of Receipts and identity of deposited securities   Face of Receipt  - Top Center.
         
  Terms of Deposit:    
       
  (i) The amount of deposited securities represented by one American Depositary Share (“ADSs”)   Face of Receipt  - Upper right corner.
         
  (ii) The procedure for voting, if any, the deposited securities   Reverse of Receipt  - Paragraphs (17) and (18).
         
  (iii) The collection and distribution of dividends   Reverse of Receipt - Paragraph (15).
         
  (iv) The transmission of notices, reports and proxy soliciting material   Face of Receipt  - Paragraph (14);
Reverse of Receipt – Paragraphs (17) and (18).
         
  (v) The sale or exercise of rights   Reverse of Receipt – Paragraphs (15) and (17).
         
  (vi) The deposit or sale of securities resulting from dividends, splits or plans of reorganization  

Face of Receipt – Paragraph (6);

Reverse of Receipt - Paragraphs (15), (17), and (19).

         
  (vii) Amendment, extension or termination of the deposit agreement   Reverse of Receipt - Paragraphs (23) and (24) (no provision for extensions).
         
  (viii) Rights of holders of Receipts to inspect the transfer books of the Depositary and the list of holders of ADSs   Face of Receipt - Paragraph (14).

 

 C: 

I- C: 1

 

Item Number and Caption  

Location in Form of American

Depositary Receipt (“Receipt”)

Filed Herewith as Prospectus

     
  (ix) Restrictions upon the right to deposit or withdraw the underlying securities   Face of Receipt – Paragraphs (2), (4), (6), (7), (9), and (10).
         
  (x) Limitation upon the liability of the Depositary  

Face of Receipt – Paragraph (8);

Reverse of Receipt - Paragraphs (20) and (21).

         
  (xi) Fees and charges which may be imposed directly or indirectly on holders of ADSs   Face of Receipt - Paragraph (11).
         
Item 2.                         AVAILABLE INFORMATION   Face of Receipt - Paragraph (14).

 

Hexindai Inc. (the “Company”) is subject to the periodic reporting requirements of the United States Securities Exchange Act of 1934, as amended, and, accordingly, is required to file or submit certain reports with, and submits certain reports to, the United States Securities and Exchange Commission (the “Commission”). These reports can be retrieved from the Commission’s internet website (www.sec.gov), and can be inspected and copied at the public reference facilities maintained by the Commission (as of the date of this Post-Effective Amendment No. 1 to Registration Statement on Form F-6) at 100 F Street, N.E., Washington D.C. 20549.

 

 C: 

I-2

 

PROSPECTUS

 

The Prospectus consists of the proposed form of American Depositary Receipt included as Exhibit A to the Form of Amendment No. 1 to Deposit Agreement, filed as Exhibit (a)(i) to this Post-Effective Amendment No. 1 to Registration Statement on Form F-6 and is incorporated herein by reference.

 

 C: 

I-3

 

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 3.EXHIBITS

 

(a)(i) Form of Amendment No. 1 to the Deposit Agreement, by and among Hexindai Inc. (the “Company”), Citibank, N.A., as depositary (the “Depositary”), and all Holders and Beneficial Owners of American Depositary Shares issued thereunder. — Filed herewith as Exhibit (a)(i).

 

(a)(ii) Deposit Agreement, dated as of November 2, 2017, by and among the Company, the Depositary, and all Holders and Beneficial Owners of American Depositary Shares issued thereunder (the “Deposit Agreement”). ¾ Filed herewith as Exhibit (a)(ii).

 

(b)       Any other agreement to which the Depositary is a party relating to the issuance of the American Depositary Shares registered hereunder or the custody of the deposited securities represented thereby. ¾ None.

 

(c)       Every material contract relating to the deposited securities between the Depositary and the issuer of the deposited securities in effect at any time within the last three years. ¾ None.

 

(d)       Opinion of counsel for the Depositary as to the legality of the securities to be registered. ¾ None.

 

(e)       Certificate under Rule 466. ¾ None.

 

(f)       Powers of Attorney for certain officers and directors and the authorized representative of the Company. ¾ Set forth on the signature pages hereto.

 

 C: 

II-1

 

Item 4.UNDERTAKINGS

 

(a)The Depositary undertakes to make available at the principal office of the Depositary in the United States, for inspection by holders of ADSs, any reports and communications received from the issuer of the deposited securities which are both (1) received by the Depositary as the holder of the deposited securities, and (2) made generally available to the holders of the underlying securities by the issuer.

 

(b)If the amount of fees charged is not disclosed in the prospectus, the Depositary undertakes to prepare a separate document stating the amount of any fee charged and describing the service for which it is charged and to deliver promptly a copy of such fee schedule without charge to anyone upon request. The Depositary undertakes to notify each registered holder of an ADS thirty (30) days before any change in the fee schedule.

 

 C: 

II-2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, Citibank, N.A., acting solely on behalf of the legal entity created by the Deposit Agreement, as amended, by and among Hexindai Inc., Citibank, N.A., as depositary, and all Holders and Beneficial Owners from time to time of American Depositary Shares issued thereunder, certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this Post-Effective Amendment No. 1 to Registration Statement on Form F-6 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on the 10th day of August, 2020.

 

  Legal entity created by the Deposit Agreement, as amended, under which the American Depositary Shares registered thereunder are issued, each American Depositary Share representing the right to receive the specified number of ordinary shares of Hexindai Inc.
     
  CITIBANK, N.A., solely in its capacity as Depositary
     
  By: /s/ Richard Etienne
    Name: Richard Etienne
    Title:   Attorney-in-Fact

 

 C: 

II-3

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, Hexindai Inc. certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this Post-Effective Amendment No. 1 to Registration Statement on Form F-6 to be signed on its behalf by the undersigned thereunto duly authorized, in Beijing, China, on August 10, 2020.

 

  Hexindai Inc.
     
  By: /s/ Rui (Kerrie) Zhang
    Name: Rui (Kerrie) Zhang
    Title:   Chief Financial Officer

 

 C: 

II-4

 

POWERS OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Xiaobo An and Rui (Kerrie) Zhang to act as his/her true and lawful attorney-in-fact and agent, with full power of substitution, for him/her and in his/her name, place and stead, in any and all such capacities, to sign any and all amendments, including post-effective amendments, and supplements to this Registration Statement, and to file the same, with all exhibits thereto and other documents in connection therewith, with the United States Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as s/he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Post-Effective Amendment No. 1 to Registration Statement on Form F-6 has been signed by the following persons in the following capacities on August 10, 2020.

 

Signature   Title
     

/s/ Xiaobo An

 

Director, Chairman and Chief Executive Officer

Xiaobo An   (Principal Executive Officer)
     

/s/ Rui (Kerrie) Zhang

 

Chief Financial Officer

Rui (Kerrie) Zhang   (Principal Financial and Accounting Officer)
     

/s/ Luping Wei

 

Director and Vice President of Operations

Luping Wei    
     

/s/ Dagang Guo

 

Independent Director

Dagang Guo    
     

/s/ Stephen Markscheid

 

Independent Director

Stephen Markscheid    
     

/s/ David Wei Tang

 

Independent Director

David Wei Tang    

 

 C: 

II-5

 

Pursuant to the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Hexindai Inc., has signed this Post-Effective Amendment No. 1 to Registration Statement on Form F-6 in New York, the U.S., on August 10, 2020.

 

Authorized U.S. Representative:  
     
COGENCY GLOBAL INC.  
     
By: /s/ Colleen A. De Vries  
  Name: Colleen A. De Vries  
  Title:   Senior Vice President  

 

 C: 

II-6

 

Index to Exhibits

 

Exhibit Document

Sequentially

Numbered Page

(a)(i) Form of Amendment No. 1 to Deposit Agreement  
(a)(ii) Deposit Agreement  

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘F-6 POS’ Filing    Date    Other Filings
Filed on / Effective on:8/10/206-K
11/2/17CERTNAS
 List all Filings 


7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/14/23  Akso Health Group                 20-F        3/31/23   96:8.5M                                   EdgarAgents LLC/FA
12/29/22  Akso Health Group                 20-F        3/31/22  115:13M                                    Toppan Merrill/FA
 7/28/21  Akso Health Group                 20-F        3/31/21  119:12M                                    Toppan Merrill/FA
 2/23/21  Akso Health Group                 F-3/A                  4:352K                                   Toppan Merrill-FA
 1/26/21  Akso Health Group                 F-3                    8:650K                                   Toppan Merrill-FA
11/12/20  Akso Health Group                 F-3                    4:327K                                   Toppan Merrill-FA
 8/14/20  Akso Health Group                 20-F        3/31/20  124:14M                                    Toppan Merrill/FA
Top
Filing Submission 0001193805-20-000990   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 1:55:57.3pm ET